Molecule Details
InChIKeyAQHMBDAHQGYLIU-XNFHFXFQSA-N
Compound NameScy-635
Canonical SMILESC/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)[C@H](SCCN(C)C)C(=O)N(C)[C@@H](CC(C)(C)O)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)4
Pfam Stratification Cross-Family
Avg pChEMBL8.15
SourceChEMBL
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB12451
Drug NameSCY-635
CAS Number210759-10-7
Groups investigational
ATC Codes nan
DescriptionSCY-635 has been investigated for the treatment of Chronic Hepatitis C and Hepatitis C Infection.

Categories: Amino Acids, Peptides, and Proteins Peptides Peptides, Cyclic
Cross-references: BindingDB: 50136473 CHEMBL1269597 ChemSpider: 4980198 PubChem:6479267 PubChem:347828692
Target Activities (4)
Target Gene Organism Category Pfam pChEMBL Type Source
P30405 PPIF Homo sapiens Human PF00160 8.5 Kd ChEMBL
P62937 PPIA Homo sapiens Human PF00160 8.5 IC50 ChEMBL
P23284 PPIB Homo sapiens Human PF00160 8.3 IC50 ChEMBL
Q72547 pol Human immunodeficiency virus type 1 Pathogen PF00075 PF00078 PF06815 PF06817 7.3 IC50 ChEMBL
DrugBank Target Actions (1)
Target Gene Target Name Action Type
P49069 P49069 Guided entry of tail-anchored proteins factor CAMLG modulator targets